Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/20/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
23 | |
| 04/29/10 | 8-K | Current report filing |
|
3 | |
| 04/09/10 | 8-K | Current report filing |
|
2 | |
| 03/30/10 | 8-K | Current report filing |
|
2 | |
| 03/22/10 | 8-K | Current report filing |
|
3 | |
| 03/17/10 | 8-K | Current report filing |
|
4 | |
| 03/15/10 | 8-K | Current report filing |
|
2 | |
| 03/12/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
62 | |
| 01/19/10 | 8-K | Current report filing |
|
5 | |
| 12/04/09 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
41 |
